STAT3 and non-small cell lung carcinoma: Meng et al. showed that SOCS3, derived from STAT3 activation, can directly bind to KEAP1 to prevent the degradation of NRF2, resulting in the activation of an NRF2-dependent transcriptional program in non-small cell lung cancer cells.